PharmaState Is Official Media Partner For DUPHAT 2022. Click the banner to explore more...spot_imgspot_imgspot_img

Amgen’s first ever drug that prevents migraines – Aimovig (Erenumab)

-

For details on Aimovig (Erenumab), Migraine Disease Burden & Market Size Aimovig_New_Drug_Approval

Aimovig

EMA Approval on 31st July, 2018 of Aimovig (erenumab) for the prevention of migraine in adults experiencing four or more migraine days per month. This EMA approval is applicable to all 28 European Union member states plus Iceland, Norway and Liechtenstein.

EMAAimovig pharmastate

References:

EMA Approval

FDA Approval pi

For any Feedback or suggestion mail at: info@pharmastate.com

Weblink – https://pharmastate.com

Applink- https://goo.gl/mS8Lr7

PharmaState Blog
This is a platform for people working in the pharmaceuticals industry for Discussions, Jobs, News updates, Professional Profile display space and company business pages. PharmaState DNA is having four pillars: Quality, Transparency, Innovation & Benchmarks.

Share this article

Recent posts

Popular categories

Leave a Reply

Recent comments

Business Alnavedic on History of Indian Pharma Industry
Ahmed Mohamed Elkhodragy on MACO Calculation
Jennifer Osunde on DEFECTS IN UNCOATED TABLETS
Vinod on DEVIATION
Sunil Kumar M on SITE ACCEPTANCE TEST (SAT)
Khalid on IQ Protocol
Khalid on IQ Protocol
Nagabooshanam on Calibration of Reactor
PharmaState Blog on SOP for Sampling
Swapnil Khodake on TOOLING FOR TABLETING
%d bloggers like this: